☰

Parminder Vig

Affiliations: 
The University of Mississippi Medical Center, Jackson, MS, United States 
Area:
Biochemistry, Neuroscience Biology, Neurobiology Biology
Google:
"Parminder Vig"
Mean distance: 53433
 
Tree Publications Grants Similar researchers PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee
Scoty Hearst grad student 2012 University of Mississippi Medical Center

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Sharma A, Grill MF, Spritzer S, et al. (2019) Malignant Glial Neuronal Tumors After West Nile Virus Neuroinvasive Disease: A Coincidence or a Clue? The Neurohospitalist. 9: 160-164
Hearst SM, Shao Q, Lopez M, et al. (2014) Focused cerebellar laser light induced hyperthermia improves symptoms and pathology of polyglutamine disease SCA1 in a mouse model. Cerebellum (London, England). 13: 596-606
Hearst SM, Shao Q, Lopez M, et al. (2014) The design and delivery of a PKA inhibitory polypeptide to treat SCA1. Journal of Neurochemistry. 131: 101-14
Vig PJ, Hearst SM, Shao Q, et al. (2014) Knockdown of acid-sensing ion channel 1a (ASIC1a) suppresses disease phenotype in SCA1 mouse model. Cerebellum (London, England). 13: 479-90
Vig PJ, Wei J, Shao Q, et al. (2012) Suppression of calbindin-D28k expression exacerbates SCA1 phenotype in a disease mouse model. Cerebellum (London, England). 11: 718-32
Hearst S, Lopez M, Shao Q, et al. (2012) D2R Agonist Bromocriptine Improves Neurodegeneration in Spinocerebellar Ataxia Type 1 Mouse Model (P05.021) Neurology. 78: P05.021-P05.021
Hearst SM, Walker LR, Shao Q, et al. (2011) The design and delivery of a thermally responsive peptide to inhibit S100B-mediated neurodegeneration. Neuroscience. 197: 369-80
Vig PJ, Hearst S, Shao Q, et al. (2011) Glial S100B protein modulates mutant ataxin-1 aggregation and toxicity: TRTK12 peptide, a potential candidate for SCA1 therapy. Cerebellum (London, England). 10: 254-66
Hearst SM, Lopez ME, Shao Q, et al. (2010) Dopamine D2 receptor signaling modulates mutant ataxin-1 S776 phosphorylation and aggregation. Journal of Neurochemistry. 114: 706-16
Vig PJ, Shao Q, Subramony SH, et al. (2009) Bergmann glial S100B activates myo-inositol monophosphatase 1 and Co-localizes to purkinje cell vacuoles in SCA1 transgenic mice. Cerebellum (London, England). 8: 231-44
See more...